About James Grabau
Form D filings for Objective Biotechnology in 2024 list James Grabau as CEO.
James Grabau first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name James Grabau in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Grabau works with at each company, as listed on that company's latest Form D.
Objective Biotechnology, Inc. · Form D, Nov 26, 2024
DS
Daniel Surinach
Executive officer and director
AJ
Amey Joshi
Executive officer and director
SK
Suhasa Kodandaramaiah
Executive officer and director
AA
Andrew Alegria
Executive officer and director
DG
Daryl Gohl
Executive officer and director